{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:44:56Z","timestamp":1785905096368,"version":"3.56.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000061","name":"National Institutes of Health Fogarty International Center","doi-asserted-by":"publisher","award":["D43 TW010547"],"award-info":[{"award-number":["D43 TW010547"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031719","name":"Fakulteit Geneeskunde en Gesondheidswetenskappe, Universiteit Stellenbosch","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031719","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.conctc.2026.101667","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T06:48:11Z","timestamp":1782715691000},"page":"101667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Reporting of second-generation p-values, Bayes factors and fragility indices in trials enhances assessment of clinical importance beyond p-values: a meta-epidemiologic study"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8703-1664","authenticated-orcid":false,"given":"Tonya M.","family":"Esterhuizen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5855-5461","authenticated-orcid":false,"given":"Lawrence","family":"Mbuagbaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Yanwou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7477-1265","authenticated-orcid":false,"given":"Devron J.","family":"Swaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esme","family":"Kittle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1757-2852","authenticated-orcid":false,"given":"Johann-Christoph","family":"Licht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0355-9734","authenticated-orcid":false,"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"sup1","key":"10.1016\/j.conctc.2026.101667_bib1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/00031305.2018.1537891","article-title":"Before p < 0.05 to Beyond p < 0.05: using history to Contextualize p-Values and significance testing","volume":"73","author":"Kennedy-Shaffer","year":"2019","journal-title":"Am. Stat."},{"issue":"12","key":"10.1016\/j.conctc.2026.101667_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.patter.2023.100878","article-title":"The roles, challenges, and merits of the p value","volume":"4","author":"Ch\u00e9n","year":"2023","journal-title":"Patterns"},{"issue":"2","key":"10.1016\/j.conctc.2026.101667_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","article-title":"The ASA's statement on p-Values: context, process, and purpose","volume":"70","author":"Wasserstein","year":"2016","journal-title":"Am. Statistician"},{"issue":"1","key":"10.1016\/j.conctc.2026.101667_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01973533.2015.1012991","article-title":"Editorial","volume":"37","author":"Trafimow","year":"2015","journal-title":"Basic Appl. Soc. Psychol."},{"issue":"1","key":"10.1016\/j.conctc.2026.101667_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41562-017-0189-z","article-title":"Redefine statistical significance","volume":"2","author":"Benjamin","year":"2018","journal-title":"Nat. Hum. Behav."},{"key":"10.1016\/j.conctc.2026.101667_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.econlet.2019.05.007","article-title":"How redefining statistical significance can worsen the replication crisis","volume":"181","author":"Williams","year":"2019","journal-title":"Econ. Lett."},{"issue":"14","key":"10.1016\/j.conctc.2026.101667_bib7","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/jama.2018.1536","article-title":"The proposal to lower P value thresholds to .005","volume":"319","author":"Ioannidis","year":"2018","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"10.1016\/j.conctc.2026.101667_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/d41586-019-00857-9","article-title":"Retire statistical significance","volume":"567","author":"Amrhein","year":"2019","journal-title":"Nature"},{"issue":"sup1","key":"10.1016\/j.conctc.2026.101667_bib9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/00031305.2018.1527253","article-title":"Abandon statistical significance","volume":"73","author":"McShane","year":"2019","journal-title":"Am. Stat."},{"issue":"sup1","key":"10.1016\/j.conctc.2026.101667_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/00031305.2018.1529624","article-title":"The p-Value requires context, not a threshold","volume":"73","author":"Betensky","year":"2019","journal-title":"Am. Stat."},{"issue":"21","key":"10.1016\/j.conctc.2026.101667_bib11","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1002\/sim.8293","article-title":"P value functions: an underused method to present research results and to promote quantitative reasoning","volume":"38","author":"Infanger","year":"2019","journal-title":"Stat. Med."},{"issue":"3","key":"10.1016\/j.conctc.2026.101667_bib12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJMe1906559","article-title":"New guidelines for statistical reporting in the journal","volume":"381","author":"Harrington","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.conctc.2026.101667_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/1740774519846504","article-title":"There is still a place for significance testing in clinical trials","volume":"16","author":"Cook","year":"2019","journal-title":"Clin. Trials"},{"key":"10.1016\/j.conctc.2026.101667_bib14","article-title":"CONSORT 2025 statement: updated guideline for reporting randomised trials","volume":"389","author":"Hopewell","year":"2025","journal-title":"Bmj"},{"issue":"6","key":"10.1016\/j.conctc.2026.101667_bib15","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/fampra\/cmac065","article-title":"Leveraging confidence intervals to inform the clinical significance of interventions","volume":"39","author":"Fernainy","year":"2022","journal-title":"Fam. Pract."},{"issue":"4","key":"10.1016\/j.conctc.2026.101667_bib16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4065\/77.4.371","article-title":"Methods to explain the clinical significance of health status measures","volume":"77","author":"Guyatt","year":"2002","journal-title":"Mayo Clin. Proc."},{"issue":"3","key":"10.1016\/j.conctc.2026.101667_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/pst.459","article-title":"The role of the minimum clinically important difference and its impact on designing a trial","volume":"10","author":"Chuang-Stein","year":"2011","journal-title":"Pharm. Stat."},{"key":"10.1016\/j.conctc.2026.101667_bib18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1525-1497.2002.11111.x","article-title":"Determination of the clinical importance of study results A review","volume":"17","author":"Man-son-hing","year":"2002","journal-title":"JGIM"},{"issue":"8","key":"10.1016\/j.conctc.2026.101667_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2025-100411","article-title":"Disparity between statistical significance and clinical importance in published randomised controlled trials: a methodological study","volume":"15","author":"Esterhuizen","year":"2025","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.conctc.2026.101667_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nmeth.4210","article-title":"Points of significance: interpreting P values","volume":"14","author":"Altman","year":"2017","journal-title":"Nat. Methods"},{"issue":"sup1","key":"10.1016\/j.conctc.2026.101667_bib21","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1080\/00031305.2018.1543137","article-title":"Inferential statistics as descriptive statistics: there is no replication crisis if we don't expect replication","volume":"73","author":"Amrhein","year":"2019","journal-title":"Am. Stat."},{"key":"10.1016\/j.conctc.2026.101667_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00031305.2019.1583913","article-title":"Moving to a world beyond \u201cp < 0.05\u201d","author":"Wasserstein","year":"2019","journal-title":"Am. Stat."},{"issue":"sup1","key":"10.1016\/j.conctc.2026.101667_bib23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/00031305.2018.1537893","article-title":"An introduction to second-generation p-Values","volume":"73","author":"Blume","year":"2019","journal-title":"Am. Stat."},{"issue":"3","key":"10.1016\/j.conctc.2026.101667_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188299","article-title":"Second-generation p-values: improved rigor, reproducibility, & transparency in statistical analyses","volume":"13","author":"Blume","year":"2018","journal-title":"PLoS One"},{"issue":"430","key":"10.1016\/j.conctc.2026.101667_bib45","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/01621459.1995.10476572","article-title":"Bayes factors","volume":"90","author":"Kass","year":"1995","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.conctc.2026.101667_bib46","doi-asserted-by":"crossref","DOI":"10.1098\/rsbl.2025.0506","article-title":"Saying 'no' with confidence: statistical approaches to test for the absence of an effect","volume":"21","author":"Halsey","year":"2025","journal-title":"Biol. Lett."},{"key":"10.1016\/j.conctc.2026.101667_bib47","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S2213-2600(20)30471-9","article-title":"Clinical trials in critical care: can a Bayesian approach enhance clinical and scientific decision making?","volume":"9","author":"Yarnell","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.conctc.2026.101667_bib25","article-title":"WINPEPI updated: computer programs for epidemiologists, and their teaching potential","volume":"8","author":"Abramson","year":"2011","journal-title":"Epidemiol. Perspect. Innovat."},{"issue":"2","key":"10.1016\/j.conctc.2026.101667_bib48","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0895-4356(90)90186-S","article-title":"The unit fragility index: an additional appraisal of \"statistical significance\" for a contrast of two proportions","volume":"43","author":"Feinstein","year":"1990","journal-title":"J. Clin. Epidemiol."},{"issue":"6","key":"10.1016\/j.conctc.2026.101667_bib36","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jclinepi.2013.10.019","article-title":"The statistical significance of randomized controlled trial results is frequently fragile: a case for a fragility index","volume":"67","author":"Walsh","year":"2014","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.conctc.2026.101667_bib28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jclinepi.2021.02.023","article-title":"A method for calculating the fragility index of continuous outcomes","volume":"136","author":"Caldwell","year":"2021","journal-title":"J. Clin. Epidemiol."},{"issue":"8","key":"10.1016\/j.conctc.2026.101667_bib42","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.12469","article-title":"Application of the reverse fragility index to statistically nonsignificant randomized clinical trial results","volume":"3","author":"Khan","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"7","key":"10.1016\/j.conctc.2026.101667_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-084375","article-title":"Disparity between statistical and clinical significance in published randomised controlled trials indexed in PubMed: a protocol for a cross-sectional methodological survey","volume":"14","author":"Esterhuizen","year":"2024","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.conctc.2026.101667_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-14-34","article-title":"The thresholds for statistical and clinical significance - a five-step procedure for evaluation of intervention effects in randomised clinical trials","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.conctc.2026.101667_bib27","series-title":"Fragility Index Calculator","author":"Kane","year":"2024"},{"key":"10.1016\/j.conctc.2026.101667_bib29","series-title":"Continuous Fragility Index Calculator","author":"Caldwell","year":"2021"},{"key":"10.1016\/j.conctc.2026.101667_bib30","unstructured":"Johnson, K. Fragilityindex. n.d. [cited 2025 22 December]; Available from: https:\/\/github.com\/kippjohnson\/fragilityindex."},{"issue":"1","key":"10.1016\/j.conctc.2026.101667_bib31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.conctc.2026.101667_bib32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/ebmed-2017-110713","article-title":"Guidelines for reporting meta-epidemiological methodology research","volume":"22","author":"Murad","year":"2017","journal-title":"Evid. Base Med."},{"key":"10.1016\/j.conctc.2026.101667_bib33","series-title":"Equivalence Testing and the Second Generation P-Value","first-page":"302","author":"Lakens","year":"2018"},{"key":"10.1016\/j.conctc.2026.101667_bib34","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1111\/add.13501","article-title":"Using bayes factors for testing hypotheses about intervention effectiveness in addictions research","volume":"111","author":"Beard","year":"2016","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.conctc.2026.101667_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0195474","article-title":"Bayesian reanalysis of null results reported in medicine : strong yet variable evidence for the absence of treatment effects","volume":"13","author":"Hoekstra","year":"2018","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.conctc.2026.101667_bib37","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1177\/03635465231202522","article-title":"The continuous fragility index of statistically significant findings in randomized controlled trials that compare interventions for anterior shoulder instability","volume":"52","author":"Al-Asadi","year":"2024","journal-title":"Am. J. Sports Med."},{"key":"10.1016\/j.conctc.2026.101667_bib38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jclinepi.2019.03.012","article-title":"The statistical significance of meta-analyses is frequently fragile: definition of a fragility index for meta-analyses","volume":"111","author":"Atal","year":"2019","journal-title":"J. Clin. Epidemiol."},{"issue":"5","key":"10.1016\/j.conctc.2026.101667_bib39","first-page":"338","article-title":"How robust are clinical trials in heart failure?","volume":"38","author":"Docherty","year":"2017","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.conctc.2026.101667_bib40","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/anae.14656","article-title":"The fragility index in peri-operative randomised trials that reported significant mortality effects in adults","volume":"74","author":"Bertaggia","year":"2019","journal-title":"Anaesthesia"},{"issue":"5","key":"10.1016\/j.conctc.2026.101667_bib41","first-page":"346","article-title":"The fragility index: a P-value in sheep's clothing?","volume":"38","author":"Carter","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.conctc.2026.101667_bib43","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jclinepi.2021.03.033","article-title":"Shifting the focus away from binary thinking of statistical significance and towards education for key stakeholders: revisiting the debate on whether it's time to de-emphasize or get rid of statistical significance","volume":"137","author":"Li","year":"2021","journal-title":"J. Clin. Epidemiol."}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865426000748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865426000748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:53:37Z","timestamp":1785902017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865426000748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":48,"alternative-id":["S2451865426000748"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2026.101667","relation":{},"ISSN":["2451-8654"],"issn-type":[{"value":"2451-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reporting of second-generation p-values, Bayes factors and fragility indices in trials enhances assessment of clinical importance beyond p-values: a meta-epidemiologic study","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2026.101667","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101667"}}